Anticancer Ribosomally Synthesized and Post-Translationally Modified Peptides from Plants: Structures, Therapeutic Potential, and Future Directions

Cancer remains a significant medical challenge, necessitating the discovery of novel therapeutic agents. Ribosomally synthesized and post-translationally modified peptides (RiPPs) from plants have emerged as a promising source of anticancer compounds, offering unique structural diversity and potent...

Full description

Saved in:
Bibliographic Details
Main Authors: Hyeon-Jeong Hwang, Youngsang Nam, Chanhee Jang, Eun La Kim, Eun Seo Jang, Yeo Jin Lee, Seoung Rak Lee
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Current Issues in Molecular Biology
Subjects:
Online Access:https://www.mdpi.com/1467-3045/47/1/6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588789759868928
author Hyeon-Jeong Hwang
Youngsang Nam
Chanhee Jang
Eun La Kim
Eun Seo Jang
Yeo Jin Lee
Seoung Rak Lee
author_facet Hyeon-Jeong Hwang
Youngsang Nam
Chanhee Jang
Eun La Kim
Eun Seo Jang
Yeo Jin Lee
Seoung Rak Lee
author_sort Hyeon-Jeong Hwang
collection DOAJ
description Cancer remains a significant medical challenge, necessitating the discovery of novel therapeutic agents. Ribosomally synthesized and post-translationally modified peptides (RiPPs) from plants have emerged as a promising source of anticancer compounds, offering unique structural diversity and potent biological activity. This review identifies and discusses cytotoxic RiPPs across various plant families, focusing on their absolute chemical structures and reported cytotoxic activities against cancer cell lines. Notably, plant-derived RiPPs such as rubipodanin A and mallotumides A–C demonstrated low nanomolar IC<sub>50</sub> values against multiple cancer cell types, highlighting their therapeutic potential. By integrating traditional ethnobotanical knowledge with modern genomic and bioinformatic approaches, this study underscores the importance of plant RiPPs as a resource for developing innovative cancer treatments. These findings pave the way for further exploration of plant RiPPs, emphasizing their role in addressing the ongoing challenges in oncology and enhancing the repertoire of effective anticancer therapies.
format Article
id doaj-art-aafe7366ac8e4d4cb9c9c0f34c4c82fa
institution Kabale University
issn 1467-3037
1467-3045
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Current Issues in Molecular Biology
spelling doaj-art-aafe7366ac8e4d4cb9c9c0f34c4c82fa2025-01-24T13:27:22ZengMDPI AGCurrent Issues in Molecular Biology1467-30371467-30452024-12-01471610.3390/cimb47010006Anticancer Ribosomally Synthesized and Post-Translationally Modified Peptides from Plants: Structures, Therapeutic Potential, and Future DirectionsHyeon-Jeong Hwang0Youngsang Nam1Chanhee Jang2Eun La Kim3Eun Seo Jang4Yeo Jin Lee5Seoung Rak Lee6College of Pharmacy, Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of KoreaCollege of Pharmacy, Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of KoreaCollege of Pharmacy, Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of KoreaCollege of Pharmacy, Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of KoreaCollege of Pharmacy, Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of KoreaCollege of Pharmacy, Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of KoreaCollege of Pharmacy, Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of KoreaCancer remains a significant medical challenge, necessitating the discovery of novel therapeutic agents. Ribosomally synthesized and post-translationally modified peptides (RiPPs) from plants have emerged as a promising source of anticancer compounds, offering unique structural diversity and potent biological activity. This review identifies and discusses cytotoxic RiPPs across various plant families, focusing on their absolute chemical structures and reported cytotoxic activities against cancer cell lines. Notably, plant-derived RiPPs such as rubipodanin A and mallotumides A–C demonstrated low nanomolar IC<sub>50</sub> values against multiple cancer cell types, highlighting their therapeutic potential. By integrating traditional ethnobotanical knowledge with modern genomic and bioinformatic approaches, this study underscores the importance of plant RiPPs as a resource for developing innovative cancer treatments. These findings pave the way for further exploration of plant RiPPs, emphasizing their role in addressing the ongoing challenges in oncology and enhancing the repertoire of effective anticancer therapies.https://www.mdpi.com/1467-3045/47/1/6phytochemicalsribosomally synthesized and post-translationally modified peptideschemical structureanticancer activitybiosynthesis
spellingShingle Hyeon-Jeong Hwang
Youngsang Nam
Chanhee Jang
Eun La Kim
Eun Seo Jang
Yeo Jin Lee
Seoung Rak Lee
Anticancer Ribosomally Synthesized and Post-Translationally Modified Peptides from Plants: Structures, Therapeutic Potential, and Future Directions
Current Issues in Molecular Biology
phytochemicals
ribosomally synthesized and post-translationally modified peptides
chemical structure
anticancer activity
biosynthesis
title Anticancer Ribosomally Synthesized and Post-Translationally Modified Peptides from Plants: Structures, Therapeutic Potential, and Future Directions
title_full Anticancer Ribosomally Synthesized and Post-Translationally Modified Peptides from Plants: Structures, Therapeutic Potential, and Future Directions
title_fullStr Anticancer Ribosomally Synthesized and Post-Translationally Modified Peptides from Plants: Structures, Therapeutic Potential, and Future Directions
title_full_unstemmed Anticancer Ribosomally Synthesized and Post-Translationally Modified Peptides from Plants: Structures, Therapeutic Potential, and Future Directions
title_short Anticancer Ribosomally Synthesized and Post-Translationally Modified Peptides from Plants: Structures, Therapeutic Potential, and Future Directions
title_sort anticancer ribosomally synthesized and post translationally modified peptides from plants structures therapeutic potential and future directions
topic phytochemicals
ribosomally synthesized and post-translationally modified peptides
chemical structure
anticancer activity
biosynthesis
url https://www.mdpi.com/1467-3045/47/1/6
work_keys_str_mv AT hyeonjeonghwang anticancerribosomallysynthesizedandposttranslationallymodifiedpeptidesfromplantsstructurestherapeuticpotentialandfuturedirections
AT youngsangnam anticancerribosomallysynthesizedandposttranslationallymodifiedpeptidesfromplantsstructurestherapeuticpotentialandfuturedirections
AT chanheejang anticancerribosomallysynthesizedandposttranslationallymodifiedpeptidesfromplantsstructurestherapeuticpotentialandfuturedirections
AT eunlakim anticancerribosomallysynthesizedandposttranslationallymodifiedpeptidesfromplantsstructurestherapeuticpotentialandfuturedirections
AT eunseojang anticancerribosomallysynthesizedandposttranslationallymodifiedpeptidesfromplantsstructurestherapeuticpotentialandfuturedirections
AT yeojinlee anticancerribosomallysynthesizedandposttranslationallymodifiedpeptidesfromplantsstructurestherapeuticpotentialandfuturedirections
AT seoungraklee anticancerribosomallysynthesizedandposttranslationallymodifiedpeptidesfromplantsstructurestherapeuticpotentialandfuturedirections